ZANATTA, ELISABETTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.050
EU - Europa 316
AS - Asia 148
AF - Africa 4
OC - Oceania 2
SA - Sud America 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.523
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.049
IT - Italia 171
CN - Cina 119
FI - Finlandia 35
SE - Svezia 29
DE - Germania 26
GB - Regno Unito 24
IN - India 15
NL - Olanda 9
IE - Irlanda 8
FR - Francia 4
JP - Giappone 3
KR - Corea 3
UA - Ucraina 3
ZA - Sudafrica 3
AU - Australia 2
BD - Bangladesh 2
BR - Brasile 2
ES - Italia 2
HK - Hong Kong 2
NO - Norvegia 2
CA - Canada 1
EU - Europa 1
GR - Grecia 1
NG - Nigeria 1
NP - Nepal 1
PK - Pakistan 1
PL - Polonia 1
RO - Romania 1
SG - Singapore 1
TR - Turchia 1
Totale 2.523
Salva come PNG Salva come JPEG
Città #
Fairfield 385
Chandler 277
Ashburn 167
Woodbridge 164
Cambridge 135
Houston 133
Seattle 117
Ann Arbor 101
Wilmington 89
Beijing 54
Padova 54
San Diego 54
Medford 34
Princeton 34
Helsinki 26
Des Moines 23
Boardman 12
Milan 12
Ogden 11
Nanjing 9
Roxbury 9
London 8
Dublin 6
New York 6
Turin 6
Caprino Veronese 5
Dearborn 5
Lappeenranta 5
Los Angeles 5
Guangzhou 4
Las Vegas 4
Naples 4
Washington 4
Borne 3
Genoa 3
Hebei 3
Hefei 3
Jinan 3
Kashiwamori 3
Kunming 3
Rome 3
Shenyang 3
Stockholm 3
Treviso 3
Yuseong-gu 3
Berlin 2
Bhopal 2
Bresso 2
Bussero 2
Capaccio 2
Cape Town 2
Ferrara 2
Glastonbury 2
Goes 2
Hong Kong 2
Hyderabad 2
Jiaxing 2
Lucca 2
Melbourne 2
Mesagne 2
New Bedfont 2
Ochtrup 2
Oslo 2
Paris 2
Phoenix 2
Pianezza 2
Recco 2
Redwood City 2
Stezzano 2
São Paulo 2
Tianjin 2
Udine 2
Verona 2
Albano Laziale 1
Atlanta 1
Baotou 1
Blackheath 1
Bloomfield 1
Borås 1
Brendola 1
Brescia 1
Bucharest 1
Buffalo 1
Bussolengo 1
Catania 1
Cerea 1
Chicago 1
Crotone 1
Delhi 1
Dongguan 1
Duncan 1
Faisalabad 1
Frosinone 1
Groningen 1
Haikou 1
Hangzhou 1
Hounslow 1
Izmir 1
Jakubowizna 1
Kharkiv 1
Totale 2.081
Salva come PNG Salva come JPEG
Nome #
IL-12 and IL-23/Th17 axis in systemic lupus erythematosus 119
Evaluation of right ventricular function performed by 3d-echocardiography in scleroderma patients 114
Therapy of scleroderma renal crisis: State of the art 112
Nailfold avascular score and coronary microvascular dysfunction in systemic sclerosis: A newsworthy association 102
Effectiveness, Tolerability, and Safety of Belimumab in Patients with Refractory SLE: a Review of Observational Clinical-Practice-Based Studies 98
SARS-CoV-2 infection in patients with autoimmune rheumatic diseases in northeast Italy: A cross-sectional study on 916 patients 96
Clinical outcomes and predictors of maternal and fetal complications in pregnancies of patients with systemic lupus erythematosus 95
Pulmonary arterial hypertension in connective tissue disorders: Pathophysiology and treatment 93
Squamous cell carcinoma antigen-IgM (SCCA-IgM) is associated with interstitial lung disease in systemic sclerosis 93
Balneotherapy in chronic inflammatory rheumatic diseases—a narrative review 90
Correction to: Effectiveness, Tolerability, and Safety of Belimumab in Patients with Refractory SLE: a Review of Observational Clinical-Practice-Based Studies. 84
COVID-19 and systemic sclerosis: clinicopathological implications from Italian nationwide survey study 81
Belimumab: a step forward in the treatment of systemic lupus erythematosus 80
Mud-bath treatment of seronegative spondyloarthritis: experience at the Euganean Thermal Area 78
How I treat patients with systemic sclerosis in clinical practice 75
The power of the EUSTAR cohort: key findings to date and implicationsfor management of systemic sclerosis patients 64
Pseudotumoral calcinosis in systemic sclerosis: Data from systematic literature review and case series from two referral centres 60
Health Assessment Questionnaire-Disability Index (HAQ-DI) use in modelling disease progression in diffuse cutaneous systemic sclerosis: an analysis from the EUSTAR database 60
Skin ulcers in systemic sclerosis: correlation with clinical phenotype in a monocentric cohort from the north-east of Italy 58
Inflammation and coronary microvascular dysfunction in autoimmune rheumatic diseases 56
NITRIC OXIDE DIFFUSION IN PATIENTS WITH SSc 55
Effects of mud-bath applications on synovial inflammation evaluated by contrasted-enhanced ultrasound (CEUS) in patients with psoriatic arthritis 53
Screening for pulmonary arterial hypertension in systemic sclerosis: A systematic literature review 53
Determinants of impairment in lung diffusing capacity in patients with systemic sclerosis 52
Safety and efficacy of rituximab biosimilar (CT-P10) in systemic sclerosis: an Italian multicentre study 50
Long-term improvement in activities of daily living in women with systemic sclerosis attending to occupational therapy. 45
Anti-MDA5 dermatomyositis: an update from bench to bedside 42
PD-1 gene rs2227981 (PD-1.5) polymorphism analysis in patients with systemic sclerosis 36
Systemic sclerosis sine scleroderma: clinical and serological features and relationship with other cutaneous subsets in a large series of patients from the national registry 'SPRING' of the Italian Society for Rheumatology 32
The interferon in idiopathic inflammatory myopathies: Different signatures and new therapeutic perspectives. A literature review 28
New onset and flare of rheumatic diseases following COVID-19 vaccination are mild and respond well to treatment: 9-month follow-up data from a single centre cohort 27
Systemic sclerosis Progression INvestiGation (SPRING) Italian registry: demographic and clinico-serological features of scleroderma spectrum 27
Systemic sclerosis sine scleroderma in children 25
Thoracic Involvement in Systemic Autoimmune Rheumatic Diseases: Pathogenesis and Management 24
Interstitial lung disease with and without progressive fibrosing phenotype in patients with idiopathic inflammatory myopathies: data from a large multicentric cohort 22
Covid-19 and rheumatic autoimmune systemic diseases: Role of pre-existing lung involvement and ongoing treatments 20
Phenotype of limited cutaneous systemic sclerosis patients with positive anti-topoisomerase I antibodies: data from EUSTAR cohort 20
Higher Ventricular-Arterial Coupling Derived from Three-Dimensional Echocardiography Is Associated with a Worse Clinical Outcome in Systemic Sclerosis 18
Primary systemic sclerosis heart involvement: A systematic literature review and preliminary data-driven, consensus-based WSF/HFA definition 18
Sex-related Differences in Systemic Sclerosis: A Multicenter Cross-sectional Study From the National Registry of the Italian Society for Rheumatology 18
Evaluation of extracellular vesicles as potential biomarkers of myositis 16
Systemic sclerosis: Recent insight in clinical management 15
The PREdictor of MAlnutrition in Systemic Sclerosis (PREMASS) Score: A Combined Index to Predict 12 Months Onset of Malnutrition in Systemic Sclerosis 14
Systemic sclerosis: state of the art on clinical practice guidelines 14
Revised European Scleroderma Trials and Research Group Activity Index is the best predictor of short-term severity accrual 13
The role of plasma exchange in the management of autoimmune disorders 13
Hypovitaminosis D in an hospitalized old population of Western Friuli 13
Cohort Enrichment Strategies for Progressive Interstitial Lung Disease in Systemic Sclerosis From European Scleroderma Trials and Research 11
CCL18 as a Biomarker of Interstitial Lung Disease (ILD) and Progressive Fibrosing ILD in Patients with Idiopathic Inflammatory Myopathies 11
MicroRNAs in idiopathic inflammatory myopathies: state-of-the-art and future perspectives 10
Size-Exclusion Chromatography Combined with Ultrafiltration Efficiently Isolates Extracellular Vesicles from Human Blood Samples in Health and Disease 10
Urinary incontinence in systemic sclerosis: a prospective multicentre cohort study 10
Geographical heterogeneity of clinical and serological phenotypes of systemic sclerosis observed at tertiary referral centres. The experience of the Italian SIR-SPRING registry and review of the world literature 9
Prevalence of diaphragm dysfunction in patients with interstitial lung disease (ILD): The role of diaphragmatic ultrasound 9
Effectiveness and safety of tocilizumab in patients with systemic sclerosis: a propensity score matched controlled observational study of the EUSTAR cohort 8
Early and Late Response and Glucocorticoid-Sparing Effect of Belimumab in Patients with Systemic Lupus Erythematosus with Joint and Skin Manifestations: Results from the Belimumab in Real Life Setting Study—Joint and Skin (BeRLiSS-JS) 8
Serum Biomarkers in Connective Tissue Disease-Associated Pulmonary Arterial Hypertension 8
Outcomes of limited cutaneous systemic sclerosis patients: Results on more than 12,000 patients from the EUSTAR database 7
Gastroesophageal Reflux Disease in Idiopathic Pulmonary Fibrosis: Viewer or Actor? To Treat or Not to Treat? 6
The Influence of Dietary Intervention in Connective Tissue Diseases: Evidence from Randomized Clinical Trials 6
Scleroderma renal crisis: Case reports and update on critical issues 5
Improvement with time of vascular outcomes in systemic sclerosis: a systematic review and meta-analysis study 5
Real-life efficacy and safety of nintedanib in systemic sclerosis-interstitial lung disease: data from an Italian multicentre study 4
Late Skin Fibrosis in Systemic Sclerosis: A Study from the EUSTAR Cohort 4
Prevalence and death rate of COVID-19 in systemic autoimmune diseases in the first three pandemic waves. Relationship to disease subgroups and ongoing therapies 3
Open questions on the management of targeted therapies for the treatment of systemic sclerosis-interstitial lung disease: results of a EUSTAR survey based on a systemic literature review 3
Capillary Desertification and Refractory Digital Ulcers in Systemic Sclerosis 3
Should we use nintedanib as early therapy in patients with SSc-ILD? 2
The clinical phenotype of systemic sclerosis patients with anti-PM/Scl antibodies: results from the EUSTAR cohort 2
Detection of Myositis Autoantibodies by Multi-Analytic Immunoassays in a Large Multicenter Cohort of Patients with Definite Idiopathic Inflammatory Myopathies 2
Incidence and risk factors for gangrene in patients with systemic sclerosis from the EUSTAR cohort 2
Glucocorticoids prescribing practices in systemic sclerosis: an analysis of the EUSTAR database 2
The Challenge of Diagnosing and Managing Pulmonary Arterial Hypertension in Systemic Sclerosis with Interstitial Lung Disease 1
Does the Impact of COVID-19 on Patients With Systemic Sclerosis Change Over Time? 1
Late skin fibrosis in systemic sclerosis: a study from the EUSTAR cohort 1
Gastroesophageal Reflux Disease in Idiopathic Pulmonary Fibrosis: Viewer or Actor? To Treat or Not to Treat? 1
Autoantibodies Targeting G-Protein-Coupled Receptors: Pathogenetic, Clinical and Therapeutic Implications in Systemic Sclerosis 1
Stratification in systemic sclerosis according to autoantibody status versus skin involvement: a study of the prospective EUSTAR cohort 1
Totale 2.627
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.664
article - articoli 14.412
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.076
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201978 0 0 0 0 0 0 0 0 0 0 40 38
2019/2020390 31 14 1 67 32 24 31 38 42 45 44 21
2020/2021579 23 28 22 41 17 22 12 47 58 28 42 239
2021/2022483 14 35 39 29 13 69 37 41 25 40 34 107
2022/2023548 86 55 18 81 75 70 7 35 65 20 19 17
2023/2024444 20 57 66 51 50 64 42 26 35 30 3 0
Totale 2.627